Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for analgesia and sedation in neonatal peripheral vein cannulation
2016-003275-22Phase 4Terminated
- Sponsor
- Region Uppsala
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in procedural pain, sponsored by Region Uppsala. Primary endpoint: Pain score (N-PASS) difference. Started Oct 2016; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
procedural pain
Beyond the preview
Go deeper on 2016-003275-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003275-22.